Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research (Q30676289)

26 June 2017

1 reference

title

Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research (English)

1 reference

26 June 2017

0 references

Mary V Solanto

1

1 reference

PubMed ID

11864719

26 June 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

Behavioural Brain Research

26 June 2017

1 reference

26 June 2017

130

1 reference

26 June 2017

1-2

1 reference

26 June 2017

65-71

1 reference

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Catecholamine regulation of the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Frontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research report

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Toward a pathophysiology of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Methylphenidate and information processing. Part 1: Differentiation between responders and nonresponders; Part 2: Efficacy in responders.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Dopamine transporter density in patients with attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Effects of methylphenidate on spatial working memory and planning in healthy young adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Comparative effects of methylphenidate and thioridazine in hyperkinetic children. I. Clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Mathematics Underlying the Rate-Dependency Hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Amphetamine-induced hypolocomotion in mice with more brain D2 dopamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Opposite effect of illumination and d-amphetamine upon activity in the squirrel monkey (Saimiri) and owl monkey (Aotes)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

The effects of age and illumination on the dose-response curves for three stimulants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Strain differences in amphetamine sensitivity in mice. I. A diallel analysis of open field activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Cognitive event-related potentials in attention deficit disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Stimulant drugs and vigilance performance: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

The action of stimulant medication in attention deficit disorder with hyperactivity: dopaminergic, noradrenergic, or both?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Performance of disturbed hyperactive and nonhyperactive children on an objective measure of hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Differential expression of autoreceptors in the ascending dopamine systems of the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Evaluation of ADHD typology in three contrasting samples: a latent class approach

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Exploratory activity: Genetic analysis of its modification by scopolamine and amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

A naturalistic assessment of the motor activity of hyperactive boys. II. Stimulant drug effects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Dextroamphetamine: Cognitive and Behavioral Effects in Normal Prepubertal Boys

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

"Paradoxical" effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Are hyperactive children deficient in attentional capacity?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Behavioral effects of low-dose methylphenidate in childhood attention deficit disorder: implications for a mechanism of stimulant drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

The effects of reinforcement and response-cost on a delayed response task in children with attention deficit hyperactivity disorder: a research note

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multimodal treatment study of AD/HD.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

A dose-response and time-action analysis of autonomic and behavioral effects of methylphenidate in attention deficit disorder with hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Hyperactivity and delay aversion--I. The effect of delay on choice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Objective measurement of hyperactivity and attentional problems in ADHD

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Combination of neuroleptic and stimulant treatment in attention deficit disorder with hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

Comparing classroom and clinic measures of attention deficit disorder: differential, idiosyncratic, and dose-response effects of methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900431-4

7 January 2021

10.1016/S0166-4328(01)00431-4

Identifiers

DOI

1 reference

26 June 2017

1 reference

PubMed ID

11864719